Header cover image

Software Healthcare Sector

Results

2251

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2251 companies

Universal Health Services

Market Cap: US$13.2b

Through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities.

UHS

US$206.84

7D

2.9%

1Y

-2.8%

Fisher & Paykel Healthcare

Market Cap: NZ$22.1b

Designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally.

FPH

NZ$37.65

7D

2.7%

1Y

8.8%

Solventum

Market Cap: US$12.8b

A healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally.

SOLV

US$73.78

7D

2.2%

1Y

11.3%

Ascendis Pharma

Market Cap: US$12.5b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

ASND

US$210.83

7D

10.0%

1Y

51.5%

Encompass Health

Market Cap: US$12.4b

Provides post-acute healthcare services in the United States and Puerto Rico.

EHC

US$123.62

7D

-1.8%

1Y

31.4%

Cochlear

Market Cap: AU$18.6b

Provides implantable hearing solutions for children and adults worldwide.

COH

AU$284.80

7D

2.0%

1Y

-2.3%

Baxter International

Market Cap: US$12.3b

Through its subsidiaries, provides a portfolio of healthcare products in the United States.

BAX

US$23.15

7D

3.4%

1Y

-35.3%

Viatris

Market Cap: US$11.9b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

VTRS

US$10.13

7D

5.3%

1Y

-10.6%

Hims & Hers Health

Market Cap: US$11.9b

Operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally.

HIMS

US$54.76

7D

-7.4%

1Y

181.7%

Moderna

Market Cap: US$11.1b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

MRNA

US$27.54

7D

8.7%

1Y

-53.1%

Roivant Sciences

Market Cap: US$11.0b

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.

ROIV

US$16.26

7D

7.7%

1Y

45.0%

Ionis Pharmaceuticals

Market Cap: US$11.0b

A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.

IONS

US$69.02

7D

7.6%

1Y

82.3%

Molina Healthcare

Market Cap: US$10.9b

Provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces.

MOH

US$200.57

7D

3.9%

1Y

-38.3%

Revvity

Market Cap: US$10.9b

Provides health sciences solutions, technologies, and services.

RVTY

US$93.38

7D

10.9%

1Y

-23.8%

Exelixis

Market Cap: US$10.8b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

EXEL

US$40.01

7D

-1.4%

1Y

52.1%

Exact Sciences

Market Cap: US$10.7b

Provides cancer screening and diagnostic test products in the United States and internationally.

EXAS

US$57.63

7D

8.0%

1Y

-16.8%

BioMarin Pharmaceutical

Market Cap: US$10.6b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

BMRN

US$55.61

7D

2.9%

1Y

-19.4%

Elanco Animal Health

Market Cap: US$10.3b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

ELAN

US$20.66

7D

5.4%

1Y

42.0%

Qiagen

Market Cap: US$10.1b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

QGEN

US$46.96

7D

6.9%

1Y

5.4%

BridgeBio Pharma

Market Cap: US$10.1b

A commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.

BBIO

US$54.61

7D

5.1%

1Y

119.8%

Ensign Group

Market Cap: US$10.0b

Provides skilled nursing, senior living, and rehabilitative services.

ENSG

US$177.22

7D

3.3%

1Y

23.5%

Penumbra

Market Cap: US$10.0b

Designs, develops, manufactures, and markets medical devices in the United States and internationally.

PEN

US$255.61

7D

1.6%

1Y

34.0%

Madrigal Pharmaceuticals

Market Cap: US$9.9b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

MDGL

US$442.31

7D

-0.2%

1Y

105.9%

Bio-Techne

Market Cap: US$9.8b

Develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.

TECH

US$61.92

7D

18.6%

1Y

-15.8%

Avantor

Market Cap: US$9.7b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

AVTR

US$14.09

7D

19.0%

1Y

-43.6%

Align Technology

Market Cap: US$9.6b

Provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally.

ALGN

US$131.50

7D

4.1%

1Y

-44.0%

DaVita

Market Cap: US$9.4b

Provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.

DVA

US$128.14

7D

-1.9%

1Y

-18.7%

Corcept Therapeutics

Market Cap: US$9.3b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

CORT

US$89.85

7D

7.1%

1Y

101.2%

Verona Pharma

Market Cap: US$9.2b

A biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs.

VRNA

US$106.79

7D

0.2%

1Y

233.2%

Caris Life Sciences

Market Cap: US$8.9b

An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.

CAI

US$32.81

7D

9.4%

1Y

n/a

Revolution Medicines

Market Cap: US$8.7b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

RVMD

US$46.58

7D

1.1%

1Y

-1.6%

Charles River Laboratories International

Market Cap: US$8.7b

Charles River Laboratories International, Inc.

CRL

US$174.95

7D

19.0%

1Y

-7.5%

Jazz Pharmaceuticals

Market Cap: US$8.5b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

JAZZ

US$137.58

7D

6.6%

1Y

26.8%

Regencell Bioscience Holdings

Market Cap: US$8.5b

Operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.

RGC

US$17.25

7D

5.2%

1Y

14,797.8%

Repligen

Market Cap: US$8.4b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

RGEN

US$150.10

7D

21.0%

1Y

9.9%

Globus Medical

Market Cap: US$8.2b

A medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.

GMED

US$60.17

7D

6.6%

1Y

-13.9%

Page 3 of 63